NNii promotes public education to sustain and build confidence that immunizations are in the best interests of children, adolescents, and adults. The network is a project of the Infectious Diseases Society of America (IDSA) and the Pediatric …

This United States Federal office is responsible for coordinating and ensuring collaboration among the many United States Federal agencies involved in vaccine and immunization activities. NVPO provides leadership and coordination among Federal …

This study, published in the journal Pediatrics, compares the neuropsychological performance, ten years after vaccination, of two groups of children exposed randomly to different amounts of thimerosal through immunization. The study concludes that, …

During seasonal influenza epidemics and previous pandemics, pregnant women have been at increased risk for complications related to influenza infection. In addition, maternal influenza virus infection and accompanying hyperthermia place fetuses at …

This editorial summarizes the characteristics of studies on rotavirus epidemiology and disease burden in Europe, published in a special supplement to the Journal of Infectious Diseases.

This article, published in the journal Pediatrics, examines whether children who received recommended vaccines on time during the first year of life had different neuropsychological outcomes at 7 to 10 years of age as compared with children with …

Pandemicfluandyou.org is a comprehensive resource guide on pandemic influenza. The site is a one-stop, easy-to-use web portal which contains the most current information and web based resources detailing how a flu pandemic might affect individuals, …

This report provides an update on the US government's progress in energizing a national pandemic influenza preparedness movement over nearly three years. The report includes a timeline of pandemic preparedness events; monitoring and …

Answers to a number of common questions, provided by the UK national immunization program.

This national parent advocacy organization is committed to protecting American children against diseases that have life-long effects on their health and development.

Respiratory syncytial virus (RSV) is responsible for serious respiratory disease in young infants. The authors of this article, published in The Pediatric Infectious Disease Journal, discuss the importance of maternal antibody in the immunity …

This article, published in Nature Genetics, describes a study using array-based sequencing of 62 isolates from a US national monitoring program to study five independent instances of vaccine escape recombination. The study observations clarify the …

This fact sheet provides information for healthcare professionals on the pneumococcal polysaccharide vaccine, including vaccination recommendations from the US Centers for Disease Control and Prevention.

This study compares the differences in US and European responses to concerns about mercury exposure from thimerisol in vaccines.

Published in the Pediatric Infectious Disease Journal, this study evaluates the impact of the introduction and routine use of seven valent pneumococcal conjugate vaccine on the epidemiology of invasive pneumococcal disease within the …

This article, published in Morbidity and Mortality Weekly Report, summarizes the Advisory Committee on Immunization Practices review of post-marketing safety surveillance data on RotaTeq®, the rotavirus vaccine by Merck & Co., Inc. The …

This article, published in Archives of Pediatrics and Adolescent Medicine, estimates the potential effect of the acceleration of administration of the first dose of pneumococcal conjugate vaccine from two months to six weeks of age. The …

International data show a low-level increased risk of intussusception associated with rotavirus vaccination. This article, published in the Pediatric Infectious Disease Journal, reports on a study that compared potential vaccine-associated …

Correct storage, handling, and administration of vaccines are vital components of a successful immunization program. However, with the large number of different healthcare professionals now involved in delivering vaccine programs on a daily …

This article, published in the journal Vaccine, reviews the incidence of vaccine-serotype invasive pneumococcal disease and other pneumococcal-associated respiratory tract diseases following the routine use of the seven-valent pneumococcal conjugate …

This website provides materials about childhood influenza vaccination in the United States. It is targeted to both consumer and healthcare professionals. Materials include fact sheets, videos, social media sharing tools, real-life stories, …

Invasive meningococcal disease (IMD) is a serious public health threat, characterized by rapid symptom onset and high fatality rate, even after treatment. Efforts to prevent IMD remain challenging, because there is neither an immunogenic vaccine for …

This report, published by the US Centers for Disease Control and Prevention (CDC), summarizes recommendations approved by the CDC's Advisory Committee on Immunization Practices (ACIP) on February 24, 2010, for the use of 13-valent …

This article, published in Advances in Therapy, reviews the development and use of palivizumab, the only drug approved for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease. Palivizumab is a monoclonal antibody that …

This study, published in the Journal of American Medical Association, evaluates the projected health and economic impact of pneumococcal conjugate vaccination of healthy US infants and young children through a cost-effectiveness analysis based …